Capstone Therapeutics
CAPS • OTC
Capstone Therapeutics is a publicly traded company trading on OTC, led by CEO Matthew E. Lipman.
CEOMatthew E. Lipman
Next Earnings
Upcoming earnings announcement for Capstone Therapeutics
Date
Thursday, February 19, 2026 (in 1 week)
Timing
Before Market Open (9:36 AM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$0.14
Revenue Estimate
$12.5M
Earnings History
Past 2 earnings reports for Capstone Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 18, 2025 | Q3 2025 | -$0.35Est: $0.12 | -391.7% | $13.7MEst: $15.6M | -12.3% | — |
| Aug 15, 2025 | Q2 2025 | -$0.13 | — | $12.9M | — | — |